Transparency in clinical trials is continually changing, and to stay on top of the news, TrialAssure brings a weekly round-up of some of the key stories surrounding disclosures in clinical trials. This week’s stories are as follows:
Make it Public –new consultation launched in Scotland to help increase public access to research findings– NHS Health Research Authority
The Health Research Authority (HRA) and the NHS Research Scotland (NRS) are seeking comments to help shape its new strategy to increase public access to research findings. The new strategy, called Make It Public, is asking individuals to complete an online survey and attend a workshop in Edinburgh to express their thoughts.
Read more about the Make It Public strategy here
U.K. patient groups demand action on trial data nondisclosure as politicians ramp up pressure – Fierce Biotech
Twelve patient and healthcare groups are complaining that the Health Research Authority (HRA) is lagging behind in clinical trial transparency. The group wants the HRA to have stronger resolve to fix clinical trial data being withheld from the public.
Ben Adams has the full story via Fierce Biotech
Free download: lay summary whitepaper – MMS Holdings
Prepared by pharmaceutical industry experts at MMS Holdings, this complimentary lay summary whitepaper explains lay summary writing, the importance of starting a pilot program, a checklist for lay reviewers, and strategic advice for becoming more transparent.
Download the free whitepaper here
